Sanibel Captiva Trust Company Inc. Has $3.69 Million Position in CME Group Inc. (NASDAQ:CME)

Sanibel Captiva Trust Company Inc. lessened its holdings in CME Group Inc. (NASDAQ:CME) by 0.7% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 16,731 shares of the financial services provider’s stock after selling 121 shares during the quarter. Sanibel Captiva Trust Company Inc.’s holdings in CME Group were worth $3,692,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. B. Riley Wealth Advisors Inc. boosted its stake in shares of CME Group by 1.3% in the 4th quarter. B. Riley Wealth Advisors Inc. now owns 3,625 shares of the financial services provider’s stock valued at $782,000 after purchasing an additional 48 shares in the last quarter. Capital Advisors Ltd. LLC grew its position in CME Group by 4.3% in the 1st quarter. Capital Advisors Ltd. LLC now owns 1,160 shares of the financial services provider’s stock valued at $250,000 after purchasing an additional 48 shares during the period. Lantz Financial LLC grew its position in CME Group by 1.1% in the 1st quarter. Lantz Financial LLC now owns 4,561 shares of the financial services provider’s stock valued at $982,000 after purchasing an additional 49 shares during the period. Lester Murray Antman dba SimplyRich grew its position in CME Group by 0.7% in the 2nd quarter. Lester Murray Antman dba SimplyRich now owns 7,667 shares of the financial services provider’s stock valued at $1,507,000 after purchasing an additional 50 shares during the period. Finally, Essex LLC grew its position in CME Group by 3.3% in the 1st quarter. Essex LLC now owns 1,649 shares of the financial services provider’s stock valued at $355,000 after purchasing an additional 52 shares during the period. 87.75% of the stock is owned by institutional investors.

Insider Buying and Selling

In other CME Group news, CFO Lynne Fitzpatrick sold 754 shares of the stock in a transaction dated Sunday, September 15th. The stock was sold at an average price of $216.99, for a total value of $163,610.46. Following the completion of the sale, the chief financial officer now directly owns 13,261 shares in the company, valued at approximately $2,877,504.39. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. In other news, Director Bryan T. Durkin sold 7,593 shares of the firm’s stock in a transaction that occurred on Friday, August 30th. The stock was sold at an average price of $214.59, for a total value of $1,629,381.87. Following the transaction, the director now owns 55,607 shares in the company, valued at $11,932,706.13. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CFO Lynne Fitzpatrick sold 754 shares of CME Group stock in a transaction that occurred on Sunday, September 15th. The stock was sold at an average price of $216.99, for a total value of $163,610.46. Following the transaction, the chief financial officer now owns 13,261 shares in the company, valued at approximately $2,877,504.39. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. 0.30% of the stock is currently owned by company insiders.

CME Group Price Performance

CME opened at $221.25 on Friday. The business has a fifty day moving average of $213.67 and a 200 day moving average of $207.83. CME Group Inc. has a 52-week low of $190.70 and a 52-week high of $226.78. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.10. The stock has a market cap of $79.66 billion, a P/E ratio of 25.17, a PEG ratio of 8.74 and a beta of 0.55.

CME Group (NASDAQ:CME) last posted its quarterly earnings data on Wednesday, July 24th. The financial services provider reported $2.56 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.53 by $0.03. CME Group had a return on equity of 12.82% and a net margin of 56.98%. The company had revenue of $1.53 billion during the quarter, compared to analysts’ expectations of $1.53 billion. During the same quarter in the previous year, the business earned $2.30 EPS. CME Group’s revenue was up 12.7% compared to the same quarter last year. As a group, sell-side analysts anticipate that CME Group Inc. will post 9.94 EPS for the current year.

CME Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, September 25th. Investors of record on Monday, September 9th were paid a dividend of $1.15 per share. This represents a $4.60 dividend on an annualized basis and a dividend yield of 2.08%. The ex-dividend date of this dividend was Monday, September 9th. CME Group’s dividend payout ratio (DPR) is currently 52.33%.

Wall Street Analysts Forecast Growth

A number of equities analysts have issued reports on the stock. Citigroup lifted their price objective on shares of CME Group from $240.00 to $250.00 and gave the stock a “buy” rating in a report on Thursday, October 3rd. JPMorgan Chase & Co. boosted their price objective on CME Group from $187.00 to $191.00 and gave the company an “underweight” rating in a research note on Thursday, July 25th. Piper Sandler upped their price target on CME Group from $225.00 to $240.00 and gave the company an “overweight” rating in a research report on Tuesday. TD Cowen initiated coverage on CME Group in a research report on Thursday, September 26th. They set a “hold” rating and a $221.00 price target on the stock. Finally, Keefe, Bruyette & Woods boosted their price objective on CME Group from $212.00 to $213.00 and gave the stock a “market perform” rating in a report on Thursday, July 25th. Four analysts have rated the stock with a sell rating, seven have issued a hold rating and three have given a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $217.71.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.